Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells.

Egusquiaguirre SP, Yeh JE, Walker SR, Liu S, Frank DA.

Neoplasia. 2018 May;20(5):489-498. doi: 10.1016/j.neo.2018.03.004. Epub 2018 Apr 2.

2.

Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndrome.

Yeh JE, Tahan SR, Burgin S.

Dermatol Online J. 2017 Aug 15;23(8). pii: 13030/qt62w694s1.

3.

Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab.

Yeh JE, Tsiaras WG.

JAAD Case Rep. 2017 Mar 9;3(2):110-112. doi: 10.1016/j.jdcr.2017.01.012. eCollection 2017 Mar. No abstract available.

4.

Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.

Toniolo PA, Liu S, Yeh JE, Ye DQ, Barbuto JA, Frank DA.

Oncotarget. 2016 Jul 19;7(29):46301-46314. doi: 10.18632/oncotarget.10093.

5.

STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy.

Yeh JE, Frank DA.

ChemMedChem. 2016 Apr 19;11(8):795-801. doi: 10.1002/cmdc.201500482. Epub 2015 Dec 10. Review.

PMID:
26662504
6.

Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Hu T, Yeh JE, Pinello L, Jacob J, Chakravarthy S, Yuan GC, Chopra R, Frank DA.

Mol Cell Biol. 2015 Oct;35(19):3284-300. doi: 10.1128/MCB.00060-15. Epub 2015 Jul 13.

7.

Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer.

Yeh JE, Kreimer S, Walker SR, Emori MM, Krystal H, Richardson A, Ivanov AR, Frank DA.

Genes Cancer. 2015 Mar;6(3-4):153-68.

8.

Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.

Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JA, Frank DA.

J Immunol. 2015 Apr 1;194(7):3180-90. doi: 10.4049/jimmunol.1401635. Epub 2015 Feb 27.

9.

STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.

Xiang M, Birkbak NJ, Vafaizadeh V, Walker SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, Richardson AL, Frank DA.

Sci Signal. 2014 Jan 28;7(310):ra11. doi: 10.1126/scisignal.2004497.

10.

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition.

Yeh JE, Toniolo PA, Frank DA.

JAKSTAT. 2013 Oct 1;2(4):e24635. doi: 10.4161/jkst.24635. Epub 2013 Apr 15.

11.

Targeting transcription factors: promising new strategies for cancer therapy.

Yeh JE, Toniolo PA, Frank DA.

Curr Opin Oncol. 2013 Nov;25(6):652-8. doi: 10.1097/01.cco.0000432528.88101.1a. Review.

PMID:
24048019
12.

STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6.

Walker SR, Nelson EA, Yeh JE, Pinello L, Yuan GC, Frank DA.

Mol Cell Biol. 2013 Aug;33(15):2879-90. doi: 10.1128/MCB.01620-12. Epub 2013 May 28.

13.

Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.

Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela-Arispe ML, Varella-Garcia M, Wu H.

Nature. 2008 May 22;453(7194):529-33. doi: 10.1038/nature06933. Epub 2008 May 7.

Supplemental Content

Support Center